The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure. Ann Med Res . 2022;29(8):846-852. Accessed October 21, 2025. http://www.annalsmedres.org/index.php/aomr/article/view/4236